(Q33332208)
Statements
1 reference
A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors (English)
1 reference
Chen HX
1 reference
Marshall JL
1 reference
Ness E
1 reference
Martin RR
1 reference
Dvorchik B
1 reference
Rizvi N
1 reference
Marquis J
1 reference
McKinlay M
1 reference
Dahut W
1 reference
Hawkins MJ
1 reference
1 reference